ArticleWorld journal of hepatology2015
Pseudolymphoma (reactive lymphoid hyperplasia) of the liver: A clinical challenge.
Article in World journal of hepatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 27 citations in OpenAlex.
- Hepatic pseudolymphoma with hepatobiliary-phase ring-like hyperintensity on gadoxetic acid-enhanced MRI: radiologic-pathologic correlation with intratumoral fibrosis.BJR case reports · 2026Article
- MR imaging findings of hepatic pseudolymphoma: common and rare features.Abdominal radiology (New York) · 2025Article
- Reactive lymphoid hyperplasia of the liver: A case report featuring characteristic nodular and perinodular enhancement.Radiology case reports · 2024Article
- A case of hepatic reactive lymphoid hyperplasia: the review of 23 cases from the literatures.Clinical journal of gastroenterology · 2023Article
- Diffusion-weighted imaging might be useful for reactive lymphoid hyperplasia diagnosis of the liver: A case report.World journal of clinical cases · 2020Article
- Primary hepatic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue.Journal of pathology and translational medicine · 2020Article
- A case of reactive lymphoid hyperplasia of the liver in a patient with autoimmune hepatitis.Surgical case reports · 2020Article
- Benign focal liver lesions masquerading as primary liver cancers on MRI.Diagnostic and interventional radiology (Ankara, Turkey) · 2020Review
- Reactive lymphoid hyperplasia of the liver: A case report.Medicine · 2019Article
- Hepatobiliary case report and literature review of hepatic reactive lymphoid hyperplasia with positive anti-smooth muscle antibody and anti-nuclear antibody tests.Translational cancer research · 2019Article
- Potential value of apparent diffusion coefficient in the evaluation of hepatic pseudolymphoma.Quantitative imaging in medicine and surgery · 2019Article
- Intrahepatic Reactive Lymphoid Hyperplasia: A Case Report and Review of the Literature.Case reports in surgery · 2018Article
- Primary mucosa-associated lymphoid tissue lymphoma of the liver: A report of two cases and review of the literature.World journal of hepatology · 2017Article
- Hepatic Pseudolymphoma with Fluorodeoxyglucose Uptake on Positron Emission Tomography.Case reports in gastroenterologyArticle
- A suspected case of hepatic reactive lymphoid hyperplasia in which EUS-fine needle aspiration contributed to the diagnosis.Endoscopic ultrasoundArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reactive lymphoid hyperplasia (RLH), also known as pseudolymphoma or nodular lymphoid lesion of the liver is an extremely rare condition, and only 51 hepatic RLH cases have been described in the literature since the first case was described in 1981. The majority of these cases were asymptomatic and incidentally found through radiological imaging. The precise etiology of hepatic RLH is still unknown, but relative high prevalence of autoimmune disorder in these cases suggests an immune-based liver disorder. Imaging features of hepatic RLH often suggest malignant lesions such as hepatocellular carcinoma and cholangiocarcinoma. In this report, we discuss two cases of hepatic RLH in patients with autoimmune hepatitis. We also present pathologic and magnetic resonance imaging findings, including one case utilizing a hepatocellular contrast agent, Eovist. Definitive diagnosis of hepatic RLH often requires surgical excision.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.